319.55MMarket Cap
LossP/E TTM
Key Figures
19.060Open
19.570High
42.54KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.25%Turnover Ratio
19.240Prev. Close
18.408Low
557.41KTurnover
LossP/E Static
2.62P/B
0.00%Div Yield TTM
-17.27%ROA
23.63052wk High
0.49Volume Ratio
-46.30MNet Profit
17.00MShares
-2.6835EPS TTM
0.21Beta
-20.79%ROE
5.58052wk Low
6.04%Amplitude
64.76%Gross Margin
319.55MMarket Cap
1.87Reward/Risk
5.34%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Prenetics Global Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 75 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 33.00.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Prenetics Global Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Prenetics Global Ltd Highlights
StrengthsRisks
Prenetics Global Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Prenetics Global Ltd Info
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Ticker SymbolPRE
CompanyPrenetics Global Ltd
CEOKwok (Samantha)
Websitehttps://ir.prenetics.com/
Shareholders
FAQs
What is the current price of Prenetics Global Ltd (PRE)?
The current price of Prenetics Global Ltd (PRE) is 18.64.
What is the symbol of Prenetics Global Ltd?
The ticker symbol of Prenetics Global Ltd is PRE.
What is the 52-week high of Prenetics Global Ltd?
The 52-week high of Prenetics Global Ltd is 23.63.
What is the 52-week low of Prenetics Global Ltd?
The 52-week low of Prenetics Global Ltd is 5.58.
What is the market capitalization of Prenetics Global Ltd?
The market capitalization of Prenetics Global Ltd is 319.55M.
Is Prenetics Global Ltd (PRE) currently rated as Buy, Hold, or Sell?
According to analysts, Prenetics Global Ltd (PRE) has an overall rating of Buy, with a price target of 33.00.
What is the Earnings Per Share (EPS TTM) of Prenetics Global Ltd (PRE)?
The Earnings Per Share (EPS TTM) of Prenetics Global Ltd (PRE) is -2.68.
